Aligos Therapeutics, Inc. · NASDAQ:ALGS
Aligos Therapeutics, Inc. shareholders
As of Sep 30, 2026, 35 institutions reported holding Aligos Therapeutics, Inc., 46.6% of its shares. Largest: Deep Track Capital, LP, Sio Capital Management, LLC and Parkman Healthcare Partners LLC. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Aligos Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Deep Track Capital, LP | 444K | 8.2% | no change | Nov 16, 2026 |
| Sio Capital Management, LLC | 327K | 6.0% | no change | Nov 16, 2026 |
| Parkman Healthcare Partners LLC | 326K | 6.0% | new | Nov 16, 2026 |
| Marshall Wace, LLP | 247K | 4.5% | no change | Nov 13, 2026 |
| Vanguard | 204K | 3.7% | no change | Nov 13, 2026 |
| Schonfeld Strategic Advisors LLC | 182K | 3.3% | new | Nov 16, 2026 |
| Woodline Partners LP | 177K | 3.3% | no change | Nov 16, 2026 |
| Baker Bros. Advisors LP | 83,055 | 1.5% | no change | Nov 16, 2026 |
| Hhlr Advisors, LTD. | 76,247 | 1.4% | no change | Nov 16, 2026 |
| D. E. Shaw & Co., Inc. | 71,528 | 1.3% | +5,065 | Nov 16, 2026 |